Sansure Biotech, Inc. Financials

Market Capitalization CN¥11.84 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	41.69
Forward PE	25.86
Price to Sales TTM	CN¥7.67
Price to Book MRQ	CN¥1.60
Enterprise to Revenue	5.31
Enterprise to EBITDA	29.16

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	18.56%
Operating Margin	19.45%
Return on Assets TTM	0.88%
Return on Equity TTM	3.12%

Income Statement

Revenue TTM	CN¥1,542,603,136
Revenue per Share TTM	CN¥2.64
Quarterly Revenue Growth	21.60%
Gross Profit TTM	CN¥1,226,074,112
EBITDA	CN¥265,786,944
Net Income to Common TTM	CN¥286,306,912
Diluted EPS TTM	CN¥0.49
Quarterly Earnings Growth YoY	13.20%

Balance Sheet

Total Cash MRQ	CN¥4,502,696,960
Total Cash per Share MRQ	CN¥7.84
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	11.36
Current Ratio MRQ	4.44
Book Value per Share MRQ	CN¥12.79

Cash Flow

Operating Cash Flow TTM	CN¥366,277,312
Levered Free Cash Flow TTM	CN¥294,906,144

688289 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	582,388,006
Float Shares	280,388,638
Avg 10 Volume	4,670,242
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	51.06%
% Held by Institutions	12.95%

Stock Price Summary

Beta	0.67
Fifty Two Week Low	CN¥16.44
Fifty Two Week High	CN¥26.36
Fifty Two Week Change	14.81%
Day 50 MA	CN¥19.99
Day 200 MA	CN¥21.30

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.55
Forward Annual Dividend Yield	2.71%
Trailing Annual Dividend Rate	CN¥0.53
Trailing Annual Dividend Yield	2.59%
Payout Ratio	91.84%
Dividend Date
Ex Dividend Date	2025-06-11
Last Split Factor
Last Split Date	2022-06-01